Profil
Melissa McCracken is currently an Independent Director at Tyra Biosciences, Inc. since 2021.
Dr. McCracken is a Director at Alpha-9 Oncology, Inc. and Ambagon Therapeutics, Inc. Dr. McCracken is a Partner at Nextech Invest AG since 2019 and a Partner at Nextech Ventures (US) LLC since 2021.
Formerly, Dr. McCracken was a Director at ImaginAb, Inc. Dr. McCracken earned a doctorate from the University of California, Los Angeles and completed undergraduate studies at the University of California, Davis.
Postes actifs de Melissa McCracken
| Sociétés | Poste | Début |
|---|---|---|
| TYRA BIOSCIENCES, INC. | Directeur/Membre du Conseil | 01/03/2021 |
Ambagon Therapeutics, Inc.
Ambagon Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Develops protein medicines | Directeur/Membre du Conseil | - |
Alpha-9 Oncology, Inc.
Alpha-9 Oncology, Inc. BiotechnologyHealth Technology Engages in research clinical stage radiopharmaceutical and drug design for cancer treatment | Directeur/Membre du Conseil | - |
Nextech Ventures Us LLC
Nextech Ventures Us LLC Investment ManagersFinance Functions as an alternative investment manager | Private Equity Investor | 01/11/2021 |
Nextech Invest AG
Nextech Invest AG Investment ManagersFinance Nextech invests in companies located in the United States and Europe. The firm focuses on the bio technology sector. It provides financing for early-stage capital requirements. | Private Equity Investor | 01/01/2019 |
Anciens postes connus de Melissa McCracken
| Sociétés | Poste | Fin |
|---|---|---|
ImaginAb, Inc.
ImaginAb, Inc. Medical SpecialtiesHealth Technology Develops radiopharmaceutical and imaging agent products | Directeur/Membre du Conseil | - |
Formation de Melissa McCracken
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Nextech Invest AG
Nextech Invest AG Investment ManagersFinance Nextech invests in companies located in the United States and Europe. The firm focuses on the bio technology sector. It provides financing for early-stage capital requirements. | Finance |
University of California, Los Angeles
University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Davis
University of California, Davis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ImaginAb, Inc.
ImaginAb, Inc. Medical SpecialtiesHealth Technology Develops radiopharmaceutical and imaging agent products | Health Technology |
Tyra Biosciences, Inc.
Tyra Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops cancer treatment drug therapies | Health Technology |
Nextech Ventures Us LLC
Nextech Ventures Us LLC Investment ManagersFinance Functions as an alternative investment manager | Finance |
Ambagon Therapeutics, Inc.
Ambagon Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Develops protein medicines | Health Technology |
Alpha-9 Oncology, Inc.
Alpha-9 Oncology, Inc. BiotechnologyHealth Technology Engages in research clinical stage radiopharmaceutical and drug design for cancer treatment | Health Technology |
















